Uncategorised - European Medical Journal

Future of AI in Aesthetic Skin Care

Recent advancements in artificial intelligence (AI) are reshaping dermatology, particularly in diagnosing skin diseases like skin cancer.

Perinatal Lead Exposure Linked to Lower Vaccine Antibody Response

Emerging research highlights critical windows of susceptibility to lead exposure that may reduce antibody responses to childhood vaccines, raising concerns for immune health.

Lupus Vasculitis, a Rare Diagnosis and a Therapeutic Challenge

More than 50% of patients with systemic lupus erythematosus (SLE) develop lupus nephritis (LN) during the disease, which may manifest with…

Cervical Cancer Screening Among Mothers Attending Antenatal and Postnatal Clinics

Cervical cancer begins in the epithelial cells of the cervix following an ongoing period of infection with high-risk types of human…

Ozanimod▼ in Ulcerative Colitis: Key New Data

A summary of the latest ozanimod data presented at UEGW and ACG 2024, confirming the continuing long-term efficacy and safety profile of…

Coagulase-Negative Staphylococcal Endocarditis: A Nationwide Study Reveals Key Trends

A large Spanish cohort study highlights the distinct clinical features, management, and outcomes of coagulase-negative staphylococcal endocarditis.

Personalising Overactive Bladder Treatment: Why BMI Matters in Choosing the Right Therapy

Women who are overweight with refractory overactive bladder respond better to botulinum toxin injections than pharmaceutical therapy, new research finds.

Genetic Analysis of 527 Cases of Rare Bleeding Disorders: EAHAD 2025

Genetic analysis of 527 rare bleeding disorder cases reveals novel variants, according to research presented at the EAHAD 2024 Annual Congress.

Reclassification of Haemophilia Carriers Improves Diagnosis and Care: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, a new system improves diagnosis and care for hemophilia carriers.

miRNA Signatures as Biomarkers for Haemophilic Arthropathy: EAHAD 2025

According to research presented at the EAHAD 2024 Annual Congress, miRNA signatures could serve as biomarkers for hemophilic arthropathy.